Compare GRMLW & ARTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRMLW | ARTC |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2022 | N/A |
| Metric | GRMLW | ARTC |
|---|---|---|
| Price | $0.12 | $9.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.7K | ★ 19.3K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $9.79 |
| 52 Week High | $0.38 | $9.99 |
| Indicator | GRMLW | ARTC |
|---|---|---|
| Relative Strength Index (RSI) | 29.55 | 52.58 |
| Support Level | N/A | $9.89 |
| Resistance Level | $0.17 | N/A |
| Average True Range (ATR) | 0.03 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 4.55 | 0.00 |
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.